Family Medicine · Richmond, KY
NPI
1033118864
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3190 Irvine Rd
Richmond, KY, 40475
Phone (859) 369-0070
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
6,739 services
Medicare patients, 2024
190
Average age 74
Drug cost, 2024
$1.6M
10,902 prescriptions
Company payments, 2025
$993
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George M Pittman was code 99214 (office e&m - established), 591 times for 180 patients. In total George M Pittman billed 6,739 services in 34 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 591 | 180 | $67.39 | $40K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 572 | 160 | $10.75 | $6,147 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 552 | 45 | $0.07 | $39.74 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 356 | 49 | $0.28 | $98.04 |
| 99213 Office E&M - Established | Office | 282 | 122 | $47.50 | $13K |
| 96372 Injection Administration | Office | 275 | 79 | $7.57 | $2,080 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 252 | 33 | $38.29 | $9,648 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 113 | 113 | $106.52 | $12K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 100 | 34 | $0.80 | $80.3 |
| 81002 Clinical Chemistry | Office | 72 | 50 | $3.41 | $246 |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 51 | 21 | $52.19 | $2,662 |
| 97760 Occupational Therapy | Office | 22 | 20 | $22.91 | $504 |
| 93000 Electrocardiogram | Office | 19 | 17 | $6.89 | $131 |
| 99215 Office E&M - Established | Office | 18 | 16 | $97.89 | $1,762 |
By year: 2022 $130K for 6,948 services; 2023 $125K for 6,332 services; 2024 $93K for 6,739 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 72 | 50 | $3.41 | $246 |
Medicare prescription drug claims, 2024
In 2024, the drug George M Pittman prescribed most often to Medicare patients was Gabapentin, with 486 prescriptions and refills. In total George M Pittman wrote 10,902 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 486 | 633 | 91 | $6,574 |
| Rosuvastatin Calcium Generic | 438 | 1,235 | 133 | $4,362 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 407 | 407 | 62 | $8,790 |
| Clonazepam Generic | 372 | 420 | 48 | $1,627 |
| Amlodipine Besylate Generic | 308 | 824 | 97 | $971 |
| Levothyroxine Sodium Generic | 232 | 606 | 72 | $2,436 |
| Famotidine Generic | 230 | 554 | 67 | $2,672 |
| Atorvastatin Calcium Generic | 195 | 529 | 61 | $1,017 |
| Pantoprazole Sodium Generic | 195 | 504 | 58 | $1,882 |
| Telmisartan Generic | 183 | 419 | 68 | $4,120 |
| Metoprolol Succinate Generic | 177 | 419 | 49 | $1,895 |
| Allopurinol Generic | 169 | 453 | 47 | $1,615 |
| Mounjaro Tirzepatide | 167 | 199 | 34 | $210K |
| Tramadol Hcl Generic | 166 | 168 | 33 | $2,900 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 165 | 165 | 23 | $3,602 |
Brand drugs: 1,846 claims; generic drugs: 8,985 claims; opioid claims: 913.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George M Pittman $993 ($993 in general payments such as food, travel and fees) from 16 companies. The largest payer was Amgen Inc. with $174.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $174 |
| Vanda Pharmaceuticals Inc. VNDA | 9 | $152 |
| Lilly USA, LLC LLY | 9 | $125 |
| Antares Pharma, Inc. | 6 | $113 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $63.72 |
| GlaxoSmithKline, LLC. GSK | 3 | $54.81 |
| Abbvie Inc. ABBV | 2 | $38.09 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.15 |
| Pfizer Inc. PFE | 2 | $34.42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $34.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.